| 注册
首页|期刊导航|浙江医学|胰岛素强化治疗对2型糖尿病患者血清CA19-9、hs- CRP的影响

胰岛素强化治疗对2型糖尿病患者血清CA19-9、hs- CRP的影响

吴丽芳 陈轩芹

浙江医学Issue(19):1635-1637,3.
浙江医学Issue(19):1635-1637,3.

胰岛素强化治疗对2型糖尿病患者血清CA19-9、hs- CRP的影响

Serum CA19-9 and CRP levels in patients with type 2 diabetes mellitus following intensive insulin therapy

吴丽芳 1陈轩芹1

作者信息

  • 1. 312500 新昌县人民医院内分泌科
  • 折叠

摘要

Abstract

Objective To investigate serum carbohydrate antigen 199(CA19- 9) and C- reactive protein levels in patients with type 2 diabetes mel itus (T2DM) after intensive insulin therapy. Methods One hundred and fifteen T2DM patients received intensive insulin therapy, including 46 patients with negative serum CA19- 9 and 69 with positive CA19- 9 at admission. The lev-els of fasting blood glucose(FPG), glycosylated hemoglobin(HbA1c), total cholesterol(TC), triglyceride(TG), high density lipopro-tein cholesterol(HDL- C), low density lipoprotein cholesterol(LDL- C) and hypersensitive C- reactive protein (hs- CRP) were de-tected at d2 of admission and the end of intensive insulin therapy. Results The mean serum CA19- 9 levels in positive and negative groups were 68.45±27.73U/ml and 26.85±10.50U/ml, respectively (P<0.05);and there were significant differences in FBG, HbA1c and hs- CRP levels between two groups before treatment. Intensive insulin therapy significantly lowered FBG, HbA1c and hs- CRP levels in both groups and the levels of CA19- 9 in positive group(P<0.05). Serum CA19- 9 was positively correlated with FBG, HbA1c and hs- CRP levels (P<0.05). Conclusion Insulin intensive therapy can control blood glucose effectively and decrease hs- CRP and HbA1c levels in T2DM patients with positive or negative CA19- 9.

关键词

糖尿病/胰岛素强化治疗/糖类抗原199/超敏C反应蛋白/空腹血糖/糖化血红蛋白

Key words

Diabetes mel itus/Insulin intensive treatment/Carbohydrate antigen 199 hypersensitive/C- reactive protein/Fasting plasma glucose/Glycosylated hemoglobin

引用本文复制引用

吴丽芳,陈轩芹..胰岛素强化治疗对2型糖尿病患者血清CA19-9、hs- CRP的影响[J].浙江医学,2014,(19):1635-1637,3.

浙江医学

OACSTPCD

1006-2785

访问量0
|
下载量0
段落导航相关论文